Eric Dessertenne
Chief Executive Officer en BIOCORP .
Cargos activos de Eric Dessertenne
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOCORP | Chief Executive Officer | 23/12/2019 | - |
| Chief Operating Officer | 09/12/2016 | 23/12/2019 | |
| Corporate Officer/Principal | 01/06/2014 | 09/12/2016 | |
| Groupement foncier agricole René PATOU | Corporate Officer/Principal | - | - |
| Aagie Sas | Chairman | - | - |
Historial de carrera de Eric Dessertenne
Antiguos cargos conocidos de Eric Dessertenne.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Brenus Pharma SAS
 Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Chief Executive Officer | - | - |
Formación de Eric Dessertenne.
| ESSEC Business School | Masters Business Admin |
| Université Blaise Pascal | Undergraduate Degree |
Estadísticas
Internacional
| Francia | 7 |
Operativa
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOCORP | Health Technology |
| Empresas privadas | 3 |
|---|---|
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Commercial Services |
| Groupement foncier agricole René PATOU | |
| Aagie Sas |
- Bolsa de valores
- Insiders
- Eric Dessertenne
- Experiencia
